- Home
- NEWP vs FULC Comparison
NEWP vs FULC Comparison
Compare NEWP & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEWP
- FULC
- Stock Information
- Founded
- NEWP 1972
- FULC 2015
- Country
- NEWP Canada
- FULC United States
- Employees
- NEWP N/A
- FULC N/A
- Industry
- NEWP
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- NEWP
- FULC Health Care
- Exchange
- NEWP Nasdaq
- FULC Nasdaq
- Market Cap
- NEWP 363.2M
- FULC 372.2M
- IPO Year
- NEWP N/A
- FULC 2019
- Fundamental
- Price
- NEWP $2.24
- FULC $7.07
- Analyst Decision
- NEWP
- FULC Buy
- Analyst Count
- NEWP 0
- FULC 8
- Target Price
- NEWP N/A
- FULC $7.13
- AVG Volume (30 Days)
- NEWP 457.8K
- FULC 395.4K
- Earning Date
- NEWP 11-12-2025
- FULC 11-12-2025
- Dividend Yield
- NEWP N/A
- FULC N/A
- EPS Growth
- NEWP N/A
- FULC N/A
- EPS
- NEWP N/A
- FULC N/A
- Revenue
- NEWP N/A
- FULC N/A
- Revenue This Year
- NEWP N/A
- FULC N/A
- Revenue Next Year
- NEWP N/A
- FULC N/A
- P/E Ratio
- NEWP N/A
- FULC N/A
- Revenue Growth
- NEWP N/A
- FULC 2752.05
- 52 Week Low
- NEWP $0.93
- FULC $2.32
- 52 Week High
- NEWP $2.24
- FULC $8.50
- Technical
- Relative Strength Index (RSI)
- NEWP 72.46
- FULC 53.37
- Support Level
- NEWP $1.88
- FULC $6.35
- Resistance Level
- NEWP $2.15
- FULC $7.87
- Average True Range (ATR)
- NEWP 0.12
- FULC 0.38
- MACD
- NEWP 0.03
- FULC 0.05
- Stochastic Oscillator
- NEWP 97.05
- FULC 47.37
About NEWP New Pacific Metals Corp.
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.